Evidence map›Paper›PMID 41908263›Full record

ArticleResearch methods in medicine & health sciences2022

Randomised evaluation of pre-notification of trial participants before self-report outcome data collection to improve retention: SWAT86.

Christopher J Sutton, Sarah Cotterill, Denise Forshaw, Sarah Rhodes, Alexandra Haig, Alison Hammond

Registry-linked trialAbstract read
In one paragraph

Article in Research methods in medicine & health sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03942783 (A Randomised Controlled Trial of Job Retention Vocational Rehabilitation for Employed People With Inflammatory Arthritis), which is not on this map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03942783 nacompletednot on this map

A Randomised Controlled Trial of Job Retention Vocational Rehabilitation for Employed People With Inflammatory Arthritis: the WORKWELL Trial.

TypeinterventionalSponsorUniversity of SalfordRan2019 to 2024Enrolled249ConditionsArthritis, Rheumatoid, Arthritis, Psoriatic, Arthritis, InflammatoryArmsWORKWELL, Control
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Strategies to improve retention in randomised trials.The Cochrane database of systematic reviews · 2021
    Pooled it
  2. Trial
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Christopher J SuttonSchool of Health Sciences, The University of Manchester, Manchester, UK.ORCID https://orcid.org/0000-0002-6406-1318
Sarah CotterillSchool of Health Sciences, The University of Manchester, Manchester, UK.ORCID https://orcid.org/0000-0001-5136-390X
Denise ForshawLancashire Clinical Trials Unit, University of Central Lancashire, Preston, UK.
Sarah RhodesSchool of Health Sciences, The University of Manchester, Manchester, UK.ORCID https://orcid.org/0000-0002-5837-801X
Alexandra HaigLancashire Clinical Trials Unit, University of Central Lancashire, Preston, UK.ORCID https://orcid.org/0000-0001-7116-3163
Alison HammondSchool of Health Sciences, University of Salford, Manchester, UK.ORCID https://orcid.org/0000-0002-5266-9991

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Retention is considered the second highest trial methods priority in the UK after recruitment. There is limited evidence on whether notifying trial participants that a follow-up questionnaire will be sent soon ('pre-notification') affects retention. Methods: This Study Within a Trial (SWAT) evaluated whether sending a pre-notification letter or email around 2 weeks before sending a self-report questionnaire increased retention, in terms of provision of the host trial primary outcome. The SWAT was a randomised, two-arm, parallel-design (1:1 allocation ratio) trial, controlled by 'no pre-notification letter'. It was embedded within the WORKWELL host trial, which evaluated the impact of job retention vocational rehabilitation on work-related and health-related outcomes of employed people with inflammatory arthritis. The SWAT primary outcome was a valid response for the WORKWELL primary outcome. Results: Two hundred forty-four trial participants took part in the SWAT. All were included in the analysis. Among those sent a pre-reminder, 100/121 (83%) provided a valid response for the WORKWELL primary outcome, compared to 97/123 (79%) of those not sent a pre-reminder. The estimated adjusted odds ratio was 1.28 (95% confidence interval 0.67-2.42), with a risk difference of 3.8% (95% CI -6.1 to 13.6%), favouring the prereminder. The estimated intervention cost per additional participant retained was £53.42, and the total cost per additional participant retained was £46.52. Conclusion: Researchers may have a small improvement in trial retention by using pre-notification. The cost per additional participant retained is relatively low. However, further evaluations are merited.

Indexed as

alternative trial design and implementation issuesdata management in clinical trialspre-notificationretentionstudy within a trialtrial conducttrial methodology

Identifiers

PMID41908263
PMCPMC13021075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.